W. Roosen

Mechanistic investigations on the etiology of Risperdal(®) Consta(®)-induced bone changes in female Wistar Hannover rats.

E. J. de Waal, L. Lammens, P. Sterkens, 2012, Toxicology.

Exacerbation of Background Nuclear Cataracts in Sprague-Dawley Rats in Embryo-Fetal Development Studies With JNJ-42165279, a Fatty Acid Amide Hydrolase Inhibitor

Marjolein van Heerden, S. Lachau-Durand, W. Roosen, 2021, Toxicologic pathology.

Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation.

R. Weaver, W. Casey, O. Doehr, 2020, Regulatory toxicology and pharmacology : RTP.

Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate.

J. V. Hoeve, G. Aguirre, G. Pandina, 2014, Regulatory toxicology and pharmacology : RTP.

A global pharmaceutical company initiative: an evidence-based approach to define the upper limit of body weight loss in short term toxicity studies.

Fiona Sewell, Sally Robinson, Kathryn Chapman, 2013, Regulatory toxicology and pharmacology : RTP.